Literature DB >> 10326784

Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats.

U C Campbell1, S T Lac, M E Carroll.   

Abstract

RATIONALE: Recent studies suggest that the GABA(B) receptor agonist, baclofen, may be a useful pharmacotherapy for cocaine abuse.
OBJECTIVES: To investigate further the effects of baclofen on maintenance and reinstatement of cocaine-reinforced behavior in rats.
METHODS: Two groups of rats were trained to self-administer IV cocaine (0.2 or 0.4 mg/kg per infusion) during daily 7-h sessions under a fixed-ratio 1 schedule. Rats were pretreated with baclofen (1.25, 2.5 or 5 mg/kg IP) or saline before the session for 5 consecutive days. An additional group of rats was trained to self-administer IV cocaine (0.4 mg/kg per infusion) during the first 2 h of daily 7-h sessions. Cocaine was replaced by saline for the remaining 5 h of the session. Once behavior had stabilized over the 7-h period, priming injections of saline (IV), cocaine (3.2 mg/kg IV) or baclofen (1.25 or 2.5 mg/kg IP) were administered prior to hour 4. Injections of baclofen (1.25 or 2.5 mg/kg IP) or saline were also given before priming injections of cocaine.
RESULTS: Pretreatment with the two higher doses of baclofen (2.5 and 5 mg/kg) decreased the number of cocaine infusions in both maintenance groups (0.2 and 0.4 mg/kg) over the 5-day treatment period. Baclofen had a greater suppressant effect on responding maintained by the lower dose of cocaine. Priming injections of baclofen (1.25 and 2.5 mg/kg) or saline did not reinstate responding. However, these same doses of baclofen dose-dependently reduced the reinstatement of responding produced by priming injections of cocaine.
CONCLUSIONS: 1) The magnitude of the suppressant effects of baclofen on maintenance of cocaine self-administration depends upon the maintenance dose, 2) baclofen may be useful in preventing reinstatement of cocaine-seeking behavior, and 3) compared to maintenance, reinstatement of responding is more sensitive to the suppressant effects of baclofen.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10326784     DOI: 10.1007/s002130050937

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

Review 2.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

3.  Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep.

Authors:  Zachary D Brodnik; David L Bernstein; Courtney D Prince; Rodrigo A España
Journal:  Behav Brain Res       Date:  2015-06-03       Impact factor: 3.332

4.  Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.

Authors:  Kimberly A Young; Teresa R Franklin; David C S Roberts; Kanchana Jagannathan; Jesse J Suh; Reagan R Wetherill; Ze Wang; Kyle M Kampman; Charles P O'Brien; Anna Rose Childress
Journal:  J Neurosci       Date:  2014-04-02       Impact factor: 6.167

5.  Differential effects of allopregnanolone on the escalation of cocaine self-administration and sucrose intake in female rats.

Authors:  Justin J Anker; Natalie E Zlebnik; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2010-08-06       Impact factor: 4.530

6.  Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal.

Authors:  Darin J Knapp; David H Overstreet; George R Breese
Journal:  Alcohol Clin Exp Res       Date:  2007-04       Impact factor: 3.455

Review 7.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

Review 8.  The reinstatement model and relapse prevention: a clinical perspective.

Authors:  David H Epstein; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

9.  Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats.

Authors:  Steven B Harrod; M Lee Van Horn
Journal:  Pharmacol Biochem Behav       Date:  2009-09-17       Impact factor: 3.533

10.  Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans.

Authors:  Joshua A Lile; William W Stoops; Timothy S Allen; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.